Mohammed Abukhattab
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.
Journal: Journal of proteome research
Published: February 03, 2026
From ticket to protection: The potential of embedding travel-clinic prompts in Qatar's airline booking systems.
Journal: Qatar medical journal
Published: December 14, 2025
Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar.
Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar.
Journal: Frontiers in immunology
Published: December 07, 2025
Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations.
Journal: Infectious diseases and therapy
Published: September 23, 2025
An epidemiological risk assessment of imported malaria cases and potential local transmission in Qatar.
Journal: European journal of public health
Published: January 13, 2025
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.
Journal: Frontiers in immunology
Published: January 08, 2025
The Spectrum of Presumed Tubercular Uveitis in a Referral Eye Clinic in Qatar.
Journal: Ocular immunology and inflammation
Published: July 09, 2024
Epidemiology, clinical characteristics, and treatment outcomes of leishmaniasis in Qatar: A retrospective study.
Journal: Qatar medical journal
Published: January 25, 2024
Clinical manifestations and outcome of Mpox infection in Qatar: An observational study during the 2022 outbreak.
Journal: Journal of infection and public health
Published: January 30, 2023
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
Journal: Medicine
Published: October 01, 2022
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 12, 2022
Last Updated: 09/26/2026